WuXi XDC Cayman (HKSE:02268) Beneish M-Score: -2.52 (As of Sep. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02268 WuXi XDC Cayman Inc HKSE:02268
50 GF Score
Price HK$71.25
! 3 Warning Signs
View Full Analysis

What is WuXi XDC Cayman Beneish M-Score?

WuXi XDC Cayman HKSE:02268 +1.86% 50 Beneish M-Score is -2.52 as of Sep. 01, 2026. GuruFocus rates HKSE:02268 with a GF Score™ of 50/100. The stock has 3 warning signs investors should review. Among 195 Medical Diagnostics & Research companies, WuXi XDC Cayman ranks worse than 60% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.52 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for WuXi XDC Cayman's Beneish M-Score or its related term are showing as below:

HKSE:02268' s Beneish M-Score Range Over the Past 10 Years
Min: -2.52   Med: -1.8   Max: -0.68
Current: -2.52

During the past 6 years, the highest Beneish M-Score of WuXi XDC Cayman was -0.68. The lowest was -2.52. And the median was -1.80.


WuXi XDC Cayman Beneish M-Score Historical Data

* Premium members only.

The historical data trend for WuXi XDC Cayman's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WuXi XDC Cayman Beneish M-Score Chart

WuXi XDC Cayman Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial 0.00 -0.68 -1.79 -1.80 -2.52

WuXi XDC Cayman Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 -1.80 0.00 -2.52 0.00

HKSE:02268 vs TMO, DHR, NTRA: Beneish M-Score Comparison

For the Diagnostics & Research subindustry, WuXi XDC Cayman's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WuXi XDC Cayman Beneish M-Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, WuXi XDC Cayman's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where WuXi XDC Cayman's Beneish M-Score falls into.


HKSE:02268
50GF Score
WuXi XDC Cayman Inc HKSE:02268
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

WuXi XDC Cayman Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of WuXi XDC Cayman for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.7705+0.528 * 0.8501+0.404 * 0.6682+0.892 * 1.5178+0.115 * 1.1067
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0353+4.679 * -0.020951-0.327 * 0.9419
=-2.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was HK$2,105 Mil.
Revenue was HK$6,567 Mil.
Gross Profit was HK$2,363 Mil.
Total Current Assets was HK$11,117 Mil.
Total Assets was HK$15,947 Mil.
Property, Plant and Equipment(Net PPE) was HK$4,502 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$163 Mil.
Selling, General, & Admin. Expense(SGA) was HK$370 Mil.
Total Current Liabilities was HK$4,050 Mil.
Long-Term Debt & Capital Lease Obligation was HK$36 Mil.
Net Income was HK$1,636 Mil.
Gross Profit was HK$0 Mil.
Cash Flow from Operations was HK$1,970 Mil.
Total Receivables was HK$1,800 Mil.
Revenue was HK$4,327 Mil.
Gross Profit was HK$1,324 Mil.
Total Current Assets was HK$6,514 Mil.
Total Assets was HK$9,742 Mil.
Property, Plant and Equipment(Net PPE) was HK$2,927 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$118 Mil.
Selling, General, & Admin. Expense(SGA) was HK$235 Mil.
Total Current Liabilities was HK$2,633 Mil.
Long-Term Debt & Capital Lease Obligation was HK$16 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2104.898 / 6566.757) / (1799.79 / 4326.549)
=0.320538 / 0.415987
=0.7705

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1323.749 / 4326.549) / (2363.364 / 6566.757)
=0.30596 / 0.359898
=0.8501

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (11117.272 + 4501.659) / 15946.912) / (1 - (6514.396 + 2927.34) / 9741.58)
=0.020567 / 0.03078
=0.6682

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=6566.757 / 4326.549
=1.5178

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(117.858 / (117.858 + 2927.34)) / (163.128 / (163.128 + 4501.659))
=0.038703 / 0.03497
=1.1067

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(369.612 / 6566.757) / (235.227 / 4326.549)
=0.056285 / 0.054368
=1.0353

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((35.612 + 4049.527) / 15946.912) / ((16.175 + 2633.405) / 9741.58)
=0.256171 / 0.271987
=0.9419

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1635.541 - 0 - 1969.638) / 15946.912
=-0.020951

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

WuXi XDC Cayman has a M-score of -2.52 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.52 mean?
WuXi XDC Cayman (HKSE:02268) has a Beneish M-Score of -2.52 as of Sep. 01, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on WuXi XDC Cayman and its competitors. According to the industry distribution chart, WuXi XDC Cayman ranks #117 out of 195 companies in the Medical Diagnostics & Research industry, placing it in the top 60%.
Is WuXi XDC Cayman's Beneish M-Score too high?
WuXi XDC Cayman's current Beneish M-Score is -2.52. Based on the distribution chart, WuXi XDC Cayman ranks #117 out of 195 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, WuXi XDC Cayman has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does WuXi XDC Cayman's Beneish M-Score compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, WuXi XDC Cayman ranks #117 out of 195 companies for Beneish M-Score. This places WuXi XDC Cayman in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Diagnostics & Research company?
A good Beneish M-Score depends on the Medical Diagnostics & Research industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on WuXi XDC Cayman and its competitors. WuXi XDC Cayman's current Beneish M-Score is -2.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WuXi XDC Cayman stock overvalued right now?
WuXi XDC Cayman (HKSE:02268) has a current Beneish M-Score of -2.52. The current Beneish M-Score is -2.52. WuXi XDC Cayman's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For WuXi XDC Cayman (HKSE:02268), the current Beneish M-Score is -2.52 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

WuXi XDC Cayman Business Description

Other Exchanges L74:Germany
Address No. 11 Xinhui Ring Road, Xinwu, Jiangsu Province, Wuxi, CHN
WuXi XDC Cayman Inc is a CRDMO focused on the ADC and broader bioconjugate market and is the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, it offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development, and manufacturing. The company provides these services from proximately located laboratories and manufacturing facilities, resulting in the reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development, and manufacturing platform, its mission is to continuously enhance its platform and propel and transform the development of the bioconjugate industry.
50GF Score

Get the complete analysis for HKSE:02268

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$71.25
Price